EPIDEMIOLOGICAL PROFILE OF STOMACH MALIGNANT NEOPLASIA IN BRAZIL BETWEEN 2017 TO 2022
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Brazilian Journal of Implantology and Health Sciences |
Texto Completo: | https://bjihs.emnuvens.com.br/bjihs/article/view/1162 |
Resumo: | INTRODUCTION: Stomach malignancy is the fifth most common cancer and the second most common cause of death from cancer worldwide. However, Brazil does not have a gastric cancer scanning protocol, only in 2018 Brazil approved a therapeutic protocol in relation to stomach cancer, mortality from gastric cancer is still high in Brazil compared to rich countries. Risk factors for the disease include Helicobacter pylori infection (90%), age, sex, smoking, physical inactivity, high consumption of salt and red meat, and diets low in fruits and vegetables. In this sense, as greater survival has already been proven in patients diagnosed early with the disease, there is a clear lack of population awareness and screening measures, which are necessary, especially in the most affected regions. OBJECTIVE: To describe the epidemiological profile of stomach malignancy between 2017 and 2022 in Brazil. METHODOLOGY: This is a descriptive cross-sectional study, with a quantitative and qualitative approach, based on the collection of data present in the SUS Hospital Information System ( SIH/SUS), hosted at DATASUS on Malignant Stomach Neoplasia, reported in Brazil between the periods of January 2017 and December 2022. The data totaled 185,146 cases in this period. The indicators used were: federation units; gender; age group; mortality; region of occurrence. For the literature review, it was pertinent to use the SciELO and PubMed database platforms. Articles published in the last 10 years were selected and focused on describing the causes, prevention, treatment and definition of problems that increase the prevalence of this disease in the Brazilian population. RESULTS: According to the data obtained, the number of hospitalizations for cases of stomach malignancy between 2017 and 2022 was 185,146, with the southeast region having the highest incidence, with 77,692 (42%) cases. Males had 118,608 (64%) cases and females had around 66,538 (36%). In relation to ethnicity, there were 78,110 (42%) cases in the white population and 9,398 (5%) in black and mixed-race people. The progression to death was 27,260 (15%) in total, with individuals between 60 and 69 years old corresponding to the highest incidence of mortality, with 7,868 cases (28%), with the North region having a mortality rate of 22.82% , higher than the national average (14.72%). CONCLUSION: Stomach Cancer's main risk factor is the bacteria Helicobacter Pylori (H. Pylori). It appears that the occurrence is greater in more populous and urbanized states, due to the large population, inadequate diet, excess salt, lack of fiber, smoking and medication. Furthermore, there is a lag in assessing lifestyle, leaving doubts regarding the protective or aggravating effect in relation to the risk of stomach cancer. |
id |
GOE-1_3ffd18c019340596b796d242031fa9bb |
---|---|
oai_identifier_str |
oai:ojs.bjihs.emnuvens.com.br:article/1162 |
network_acronym_str |
GOE-1 |
network_name_str |
Brazilian Journal of Implantology and Health Sciences |
repository_id_str |
|
spelling |
EPIDEMIOLOGICAL PROFILE OF STOMACH MALIGNANT NEOPLASIA IN BRAZIL BETWEEN 2017 TO 2022PERFIL EPIDEMIOLÓGICO DA NEOPLASIA MALÍGNA DE ESTÔMAGO NO BRASIL ENTRE 2017 A 2022Neoplasia, Maligna, Estômago, saúde pública.Neoplasm, Malignant, Stomach, public health.INTRODUCTION: Stomach malignancy is the fifth most common cancer and the second most common cause of death from cancer worldwide. However, Brazil does not have a gastric cancer scanning protocol, only in 2018 Brazil approved a therapeutic protocol in relation to stomach cancer, mortality from gastric cancer is still high in Brazil compared to rich countries. Risk factors for the disease include Helicobacter pylori infection (90%), age, sex, smoking, physical inactivity, high consumption of salt and red meat, and diets low in fruits and vegetables. In this sense, as greater survival has already been proven in patients diagnosed early with the disease, there is a clear lack of population awareness and screening measures, which are necessary, especially in the most affected regions. OBJECTIVE: To describe the epidemiological profile of stomach malignancy between 2017 and 2022 in Brazil. METHODOLOGY: This is a descriptive cross-sectional study, with a quantitative and qualitative approach, based on the collection of data present in the SUS Hospital Information System ( SIH/SUS), hosted at DATASUS on Malignant Stomach Neoplasia, reported in Brazil between the periods of January 2017 and December 2022. The data totaled 185,146 cases in this period. The indicators used were: federation units; gender; age group; mortality; region of occurrence. For the literature review, it was pertinent to use the SciELO and PubMed database platforms. Articles published in the last 10 years were selected and focused on describing the causes, prevention, treatment and definition of problems that increase the prevalence of this disease in the Brazilian population. RESULTS: According to the data obtained, the number of hospitalizations for cases of stomach malignancy between 2017 and 2022 was 185,146, with the southeast region having the highest incidence, with 77,692 (42%) cases. Males had 118,608 (64%) cases and females had around 66,538 (36%). In relation to ethnicity, there were 78,110 (42%) cases in the white population and 9,398 (5%) in black and mixed-race people. The progression to death was 27,260 (15%) in total, with individuals between 60 and 69 years old corresponding to the highest incidence of mortality, with 7,868 cases (28%), with the North region having a mortality rate of 22.82% , higher than the national average (14.72%). CONCLUSION: Stomach Cancer's main risk factor is the bacteria Helicobacter Pylori (H. Pylori). It appears that the occurrence is greater in more populous and urbanized states, due to the large population, inadequate diet, excess salt, lack of fiber, smoking and medication. Furthermore, there is a lag in assessing lifestyle, leaving doubts regarding the protective or aggravating effect in relation to the risk of stomach cancer.INTRODUÇÃO: A neoplasia maligna de estômago é o quinto câncer mais comum e a segunda causa mais comum de morte por câncer em todo o mundo. Entretanto, Brasil não tem um protocolo de escaneamento de câncer gástrico, apenas em 2018 o Brasil aprovou um protocolo terapêutico em relação ao câncer de estômago, a mortalidade de câncer gástrico ainda é alto no Brasil em relação à países ricos. Os fatores de risco para a doença incluem infecção por Helicobacter pylori (90%), idade, sexo, fumo, sedentarismo, alto consumo de sal e carnes vermelhas e dietas pobres em frutas e vegetais. Nesse sentido, como já tem-se provado a maior sobrevida em pacientes diagnosticados precocemente com a doença, é nítida a falta de medidas de conscientização da população e rastreio, que são necessárias, principalmente nas regiões mais afetadas. OBJETIVO: Descrever o perfil epidemiológico da neoplasia maligna de estômago no Brasil entre os anos de 2017 e 2022. METODOLOGIA: Trata-se de um estudo transversal descritivo, de abordagem quantitativa e qualitativa, baseado na coleta dos dados presentes no Sistema de Informação Hospitalar do SUS (SIH/SUS), hospedado no DATASUS sobre Neoplasia Maligna de Estômago, notificadas no Brasil entre os períodos de janeiro de 2017 e dezembro de 2022. Os dados totalizaram 185.146 casos nesse período. Os indicadores utilizados foram: unidades da federação; gênero; faixa etária; mortalidade; região de ocorrência. Para a revisão de literatura foi pertinente a utilização as bases de dados plataformas SciELO e PubMed. Foram selecionados artigos publicados nos últimos 10 anos e que apresentassem como foco a descrição das causas, prevenção, tratamento e definição dos problemas que potencializam a prevalência dessa doença na população brasileira. RESULTADOS: De acordo com os dados obtidos, o número de internações por casos de neoplasia maligna de estômago entre os anos de 2017 e 2022 foi de 185.146, sendo na região sudeste a maior incidência, com 77.692 (42%) casos. O sexo masculino apresentou 118.608 (64%) casos e o sexo feminino apresentou cerca de 66.538 (36%). Em relação à etnia, foram 78.110 (42%) casos na população branca e 9.398 (5%) em pretos e pardos. A progressão para óbito foi de 27.260 (15%) no total, cujos indivíduos entre 60 a 69 anos correspondem à maior incidência de mortalidade, com 7.868 casos (28%), tendo a região Norte apresentado uma taxa de mortalidade de 22,82%, maior do que a média nacional (14,72%). CONCLUSÃO: O Câncer de Estômago tem seu principal fator de risco a bactéria Helicobacter Pylori (H. Pylori). Verifica-se que a ocorrência é maior em estados mais populosos e urbanizados, devido a grande população, alimentação inadequada, excesso de sal, falta de fibras, tabagismo e medicamentos. Além disso, há uma defasagem em avaliar o estilo de vida, deixando dúvidas quanto ao efeito protetor ou agravante em relação ao risco de câncer de estômago.Specialized Dentistry Group2023-12-27info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://bjihs.emnuvens.com.br/bjihs/article/view/116210.36557/2674-8169.2023v5n5p6461-6471Brazilian Journal of Implantology and Health Sciences ; Vol. 5 No. 5 (2023): BJIHS QUALIS B3; 6461-6471Brazilian Journal of Implantology and Health Sciences ; Vol. 5 Núm. 5 (2023): BJIHS QUALIS B3; 6461-6471Brazilian Journal of Implantology and Health Sciences ; v. 5 n. 5 (2023): BJIHS QUALIS B3; 6461-64712674-8169reponame:Brazilian Journal of Implantology and Health Sciencesinstname:Grupo de Odontologia Especializada (GOE)instacron:GOEporhttps://bjihs.emnuvens.com.br/bjihs/article/view/1162/1323Copyright (c) 2023 Raffael Nazario Laurentino, Armando Nazario Ribeiro, Matheus Kalleb Almeida de Arruda Santos, Davi Rosalino Leoni, Jhennifer Oliveira Vimercati, Victor Salarolli Lorencini, Maria Clara Queiroz Alves, Sara dos Santos Carolinohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessLaurentino, Raffael NazarioRibeiro, Armando NazarioSantos, Matheus Kalleb Almeida de ArrudaLeoni, Davi RosalinoVimercati, Jhennifer OliveiraLorencini, Victor SalarolliAlves, Maria Clara QueirozCarolino, Sara dos Santos2023-12-27T20:53:59Zoai:ojs.bjihs.emnuvens.com.br:article/1162Revistahttps://bjihs.emnuvens.com.br/bjihsONGhttps://bjihs.emnuvens.com.br/bjihs/oaijournal.bjihs@periodicosbrasil.com.br2674-81692674-8169opendoar:2023-12-27T20:53:59Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE)false |
dc.title.none.fl_str_mv |
EPIDEMIOLOGICAL PROFILE OF STOMACH MALIGNANT NEOPLASIA IN BRAZIL BETWEEN 2017 TO 2022 PERFIL EPIDEMIOLÓGICO DA NEOPLASIA MALÍGNA DE ESTÔMAGO NO BRASIL ENTRE 2017 A 2022 |
title |
EPIDEMIOLOGICAL PROFILE OF STOMACH MALIGNANT NEOPLASIA IN BRAZIL BETWEEN 2017 TO 2022 |
spellingShingle |
EPIDEMIOLOGICAL PROFILE OF STOMACH MALIGNANT NEOPLASIA IN BRAZIL BETWEEN 2017 TO 2022 Laurentino, Raffael Nazario Neoplasia, Maligna, Estômago, saúde pública. Neoplasm, Malignant, Stomach, public health. |
title_short |
EPIDEMIOLOGICAL PROFILE OF STOMACH MALIGNANT NEOPLASIA IN BRAZIL BETWEEN 2017 TO 2022 |
title_full |
EPIDEMIOLOGICAL PROFILE OF STOMACH MALIGNANT NEOPLASIA IN BRAZIL BETWEEN 2017 TO 2022 |
title_fullStr |
EPIDEMIOLOGICAL PROFILE OF STOMACH MALIGNANT NEOPLASIA IN BRAZIL BETWEEN 2017 TO 2022 |
title_full_unstemmed |
EPIDEMIOLOGICAL PROFILE OF STOMACH MALIGNANT NEOPLASIA IN BRAZIL BETWEEN 2017 TO 2022 |
title_sort |
EPIDEMIOLOGICAL PROFILE OF STOMACH MALIGNANT NEOPLASIA IN BRAZIL BETWEEN 2017 TO 2022 |
author |
Laurentino, Raffael Nazario |
author_facet |
Laurentino, Raffael Nazario Ribeiro, Armando Nazario Santos, Matheus Kalleb Almeida de Arruda Leoni, Davi Rosalino Vimercati, Jhennifer Oliveira Lorencini, Victor Salarolli Alves, Maria Clara Queiroz Carolino, Sara dos Santos |
author_role |
author |
author2 |
Ribeiro, Armando Nazario Santos, Matheus Kalleb Almeida de Arruda Leoni, Davi Rosalino Vimercati, Jhennifer Oliveira Lorencini, Victor Salarolli Alves, Maria Clara Queiroz Carolino, Sara dos Santos |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Laurentino, Raffael Nazario Ribeiro, Armando Nazario Santos, Matheus Kalleb Almeida de Arruda Leoni, Davi Rosalino Vimercati, Jhennifer Oliveira Lorencini, Victor Salarolli Alves, Maria Clara Queiroz Carolino, Sara dos Santos |
dc.subject.por.fl_str_mv |
Neoplasia, Maligna, Estômago, saúde pública. Neoplasm, Malignant, Stomach, public health. |
topic |
Neoplasia, Maligna, Estômago, saúde pública. Neoplasm, Malignant, Stomach, public health. |
description |
INTRODUCTION: Stomach malignancy is the fifth most common cancer and the second most common cause of death from cancer worldwide. However, Brazil does not have a gastric cancer scanning protocol, only in 2018 Brazil approved a therapeutic protocol in relation to stomach cancer, mortality from gastric cancer is still high in Brazil compared to rich countries. Risk factors for the disease include Helicobacter pylori infection (90%), age, sex, smoking, physical inactivity, high consumption of salt and red meat, and diets low in fruits and vegetables. In this sense, as greater survival has already been proven in patients diagnosed early with the disease, there is a clear lack of population awareness and screening measures, which are necessary, especially in the most affected regions. OBJECTIVE: To describe the epidemiological profile of stomach malignancy between 2017 and 2022 in Brazil. METHODOLOGY: This is a descriptive cross-sectional study, with a quantitative and qualitative approach, based on the collection of data present in the SUS Hospital Information System ( SIH/SUS), hosted at DATASUS on Malignant Stomach Neoplasia, reported in Brazil between the periods of January 2017 and December 2022. The data totaled 185,146 cases in this period. The indicators used were: federation units; gender; age group; mortality; region of occurrence. For the literature review, it was pertinent to use the SciELO and PubMed database platforms. Articles published in the last 10 years were selected and focused on describing the causes, prevention, treatment and definition of problems that increase the prevalence of this disease in the Brazilian population. RESULTS: According to the data obtained, the number of hospitalizations for cases of stomach malignancy between 2017 and 2022 was 185,146, with the southeast region having the highest incidence, with 77,692 (42%) cases. Males had 118,608 (64%) cases and females had around 66,538 (36%). In relation to ethnicity, there were 78,110 (42%) cases in the white population and 9,398 (5%) in black and mixed-race people. The progression to death was 27,260 (15%) in total, with individuals between 60 and 69 years old corresponding to the highest incidence of mortality, with 7,868 cases (28%), with the North region having a mortality rate of 22.82% , higher than the national average (14.72%). CONCLUSION: Stomach Cancer's main risk factor is the bacteria Helicobacter Pylori (H. Pylori). It appears that the occurrence is greater in more populous and urbanized states, due to the large population, inadequate diet, excess salt, lack of fiber, smoking and medication. Furthermore, there is a lag in assessing lifestyle, leaving doubts regarding the protective or aggravating effect in relation to the risk of stomach cancer. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-12-27 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://bjihs.emnuvens.com.br/bjihs/article/view/1162 10.36557/2674-8169.2023v5n5p6461-6471 |
url |
https://bjihs.emnuvens.com.br/bjihs/article/view/1162 |
identifier_str_mv |
10.36557/2674-8169.2023v5n5p6461-6471 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://bjihs.emnuvens.com.br/bjihs/article/view/1162/1323 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Specialized Dentistry Group |
publisher.none.fl_str_mv |
Specialized Dentistry Group |
dc.source.none.fl_str_mv |
Brazilian Journal of Implantology and Health Sciences ; Vol. 5 No. 5 (2023): BJIHS QUALIS B3; 6461-6471 Brazilian Journal of Implantology and Health Sciences ; Vol. 5 Núm. 5 (2023): BJIHS QUALIS B3; 6461-6471 Brazilian Journal of Implantology and Health Sciences ; v. 5 n. 5 (2023): BJIHS QUALIS B3; 6461-6471 2674-8169 reponame:Brazilian Journal of Implantology and Health Sciences instname:Grupo de Odontologia Especializada (GOE) instacron:GOE |
instname_str |
Grupo de Odontologia Especializada (GOE) |
instacron_str |
GOE |
institution |
GOE |
reponame_str |
Brazilian Journal of Implantology and Health Sciences |
collection |
Brazilian Journal of Implantology and Health Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE) |
repository.mail.fl_str_mv |
journal.bjihs@periodicosbrasil.com.br |
_version_ |
1796798442942496768 |